AltruBio to Present at BIO CEO & Investor Conference
Published on: Sunday 06 February 2022
SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, today announced that president and chief executive officer Judy Chou, Ph.D., will present an in-person corporate overview at the BIO CEO & Investor Conference taking place February 14-17, 2022 in New York, NY. Dr. Judy Chou’s presentation will hig